Pilot Study of Lemborexant for Insomnia in Cancer Patients with Delirium

Delirium occurs very frequently in cancer patients. Insomnia is a symptom of delirium. Lemborexant is a drug that regulates sleep–wake rhythms without causing extrapyramidal symptoms. Based on its ability to improve sleep, lemborexant is expected to have efficacy for insomnia with delirium. The purp...

Descripción completa

Detalles Bibliográficos
Autores principales: Terada, Tatsuto, Hirayama, Takatoshi, Sadahiro, Ryoichi, Wada, Saho, Nakahara, Rika, Matsuoka, Hiromichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081046/
https://www.ncbi.nlm.nih.gov/pubmed/35099287
http://dx.doi.org/10.1089/jpm.2021.0509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081046/
https://www.ncbi.nlm.nih.gov/pubmed/35099287
http://dx.doi.org/10.1089/jpm.2021.0509

Ejemplares similares